Moreover, in comparing 100 Circulating Tumor Cells (CTC) negative and 100 CTC positive patients with breast cancer, researchers found that VEGF increased in CTC-negative patients, suggesting that it could serve as a potential biomarker (59). The gene discussed is VEGFA; the disease is neoplasm.